The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination
1 other identifier
observational
136
1 country
1
Brief Summary
The main aim of the investigator study is the success of predictivity cervical consistency index (CCI), anterior uterocervical angle (aUCA) and posterior uterocervical angle (pUCA) in second trimester terminations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2022
CompletedFirst Submitted
Initial submission to the registry
April 4, 2023
CompletedFirst Posted
Study publicly available on registry
December 11, 2023
CompletedDecember 11, 2023
December 1, 2023
6 months
April 4, 2023
December 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
success of predictivity cervical consistency index, anterior uterocervical angle and posterior uterocervical angle
cervical consistency index (CCI), an ultrasound measurement that aims to estimate cervical softness by measuring the anteroposterior diameter of the uterine cervix before (AP) (millimeter) and at maximal compression (AP') with the vaginal ultrasound probe and calculating the ratio between the two measurements (AP'/AP × 100). Uterocervical angle (UCA) (degree):Transvaginal sonographic images showing technique of measurement of uterocervical angle. UCA was calculated as angle between two lines. The first line was drawn between internal (I) and external ostium (os) (E). The second line was drawn 3 cm parallel to the lower aspect of anterior inner uterine wall passing through the end of the first line at internal os. (in degrees)
6 months
Secondary Outcomes (1)
compare the measured ultrasonographic values
6 months
Study Arms (2)
Pregnant women who abort within 24 hours
Group 1 treatment was completed in the first 24 hours ( who were completely aborted and removed the fetal material and its attachments )
Pregnant women who abort within 24- 48 hours
Group 2 consisted of patients who needed additional cycles and aborted within 24-48 hours.
Interventions
second trimester medical termination
Eligibility Criteria
white people same demographics no socio- cultural difference
You may qualify if:
- women who had a termination indication in the second trimester and had abortion or abortion in our hospital
- women who have had a miscarriage or abortion with a normal vaginal route or hysterotomy
You may not qualify if:
- multiple pregnancies
- pregnant women with misoprostol-related allergies
- scar pregnancies or heterotopic pregnancies
- patients with a history of previous conization or cervical surgery,
- patients with placental invasion anomaly
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nefise Nazlı YENIGUL
Bursa, 16110, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D. Assistant Professor Department of Obstetrics and Gynecology
Study Record Dates
First Submitted
April 4, 2023
First Posted
December 11, 2023
Study Start
February 15, 2022
Primary Completion
August 15, 2022
Study Completion
August 15, 2022
Last Updated
December 11, 2023
Record last verified: 2023-12